Chronic Rhinosinusitis With Nasal Polyps Global Market Report 2025
상품코드:1825669
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
비용종을 동반한 만성 부비동염 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.5%로 성장할 전망이며, 60억 8,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 생물학적 요법의 확대, 맞춤형 의료 증가, 기술의 진보, 규제 당국에 의한 승인 증가, 환자 중심 의료의 확대, 역학적 동향의 모니터링 등에 기인할 것으로 보입니다. 예측 기간 주요 동향에는 혁신적인 약물 전달 시스템, 병태 생리학 이해, 임상시험, 종단 연구, 인지도 향상, 통합 케어 모델, 유병률, 발생률 등이 포함됩니다.
향후 5년간의 성장률 8.5%라고 하는 예측은 이 시장 전회 예측으로부터 0.5%라고 하는 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 관세 인상은 벨기에나 이탈리아에서 조달하는 생물학적 제제(듀필맙) 및 내시경하 부비동 수술 기구의 가격을 밀어 올리고 수술 지연을 악화시켜 이비인후과 수술 비용을 증가시킴으로써 미국의 이비인후과 전문의에게 부담을 강요할 가능성이 있습니다. 또한 상호 관세와 무역 긴장 증가 및 제한으로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더 광범위하게 늘어날 것으로 보입니다.
호흡기 질환의 유병률 증가는 비용종을 동반한 만성 부비동염 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질병은 폐와 기도를 포함한 호흡기 시스템에 영향을 미치며 대기 오염, 흡연, 기후 변화, 감염, 직업 노출, 알레르기 등의 요인에 의해 영향을 받습니다. 천식과 만성 폐색성 폐질환(COPD)과 같은 질병은 점점 흔해지고 있으며, CRSwNP와 같은 관련 질환의 이환율 상승으로 이어지고 있습니다. 이 동향은 진단 도구, 치료 및 수술 개입에 대한 수요에 박차를 가하고 있습니다. 예를 들어, 미국 건전 통계 센터(NCHS)의 최근 데이터에 따르면 미국 성인의 천식 유병률은 2021년 8.4%에서 2022년 8.7%로 증가했으며, 천식 에피소드는 동기화 기간 동안 3.3%에서 3.7%로 증가하고 있습니다. 호흡기 감염이 더욱 흔해짐에 따라, 비용종을 동반한 만성 부비동염 시장의 성장이 더욱 자극될 것으로 예측됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 비용종을 동반한 만성 부비동염 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 비용종을 동반한 만성 부비동염 시장 : 성장률 분석
세계의 비용종을 동반한 만성 부비동염 시장 실적 : 규모 및 성장(2019-2024년)
세계의 비용종을 동반한 만성 부비동염 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 비용종을 동반한 만성 부비동염 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 비용종을 동반한 만성 부비동염 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
의약품
외과적 치료법
세계의 비용종을 동반한 만성 부비동염 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
비강
오랄
기타 투여 경로
세계의 비용종을 동반한 만성 부비동염 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 비용종을 동반한 만성 부비동염 시장 : 의약품 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
코르티코스테로이드(점비 스프레이, 경구 스테로이드)
생물학적 제제(듀피루맙과 같은 단일클론항체)
항생제
항히스타민제
류코트리엔 조절제
세계의 비용종을 동반한 만성 부비동염 시장 : 수술 방법 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
내시경하 부비강 수술(ESS)
폴립 절제술(폴립 제거)
풍선 사이나 플러시
제7장 지역별 및 국가별 분석
세계의 비용종을 동반한 만성 부비동염 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 비용종을 동반한 만성 부비동염 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
비용종을 동반한 만성 부비동염 시장 : 경쟁 구도
비용종을 동반한 만성 부비동염 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bristol-Myers Squibb Company
AstraZeneca PLC
Novartis AG
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Medtronic plc
Boehringer Ingelheim International GmbH
Amgen Inc
Teva Pharmaceutical Industries Ltd
Regeneron Pharmaceuticals Inc
Daiichi Sankyo Company Limited
Olympus Corporation
Eisai Co Ltd
Smith & Nephew PLC
Genentech USA Inc
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
비용종을 동반한 만성 부비동염 시장(2029년) : 새로운 기회를 제공하는 국가
비용종을 동반한 만성 부비동염 시장(2029년) : 새로운 기회를 제공하는 부문
비용종을 동반한 만성 부비동염 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is an enduring inflammatory condition affecting the sinuses and nasal passages, characterized by the development of nasal polyps. These polyps are benign, swollen tissues that form in response to ongoing inflammation in the nasal passages or sinuses. Diagnosis typically involves evaluating symptoms, conducting clinical examinations, utilizing imaging techniques, allergy tests, and occasionally performing biopsies.
The primary treatments for chronic rhinosinusitis with nasal polyps encompass both pharmaceutical and surgical approaches. Medications aim to alleviate inflammation, manage symptoms, and reduce the size of polyps. They can be administered via nasal sprays, orally, or through other routes, and are available through hospital pharmacies, retail outlets, and online platforms.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The chronic rhinosinusitis with nasal polyps market research report is one of a series of new reports from the business research company that provides chronic rhinosinusitis with nasal polyps market statistics, including chronic rhinosinusitis with nasal polyps industry global market size, regional shares, competitors with an chronic rhinosinusitis with nasal polyps market share, detailed chronic rhinosinusitis with nasal polyps market segments, market trends and opportunities, and any further data you may need to thrive in the chronic rhinosinusitis with nasal polyps industry. This chronic rhinosinusitis with nasal polyps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The chronic rhinosinusitis with nasal polyps market size has grown strongly in recent years. It will grow from $4.02 billion in 2024 to $4.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing prevalence, growing advancements in diagnosis, increasing treatment innovation, growing patient awareness, and increasing healthcare spending.
The chronic rhinosinusitis with nasal polyps market size is expected to see strong growth in the next few years. It will grow to $6.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to growing biologic therapies, increasing personalized medicine, advancing technological advancements, increasing regulatory approvals, growing patient-centric care, and monitoring epidemiological trends. Major trends in the forecast period include innovative drug delivery systems, understanding pathophysiology, clinical trials, longitudinal studies, increased awareness, integrated care models, prevalence, and incidence.
The forecast of 8.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. Ear, Nose, and Throat(ENT) specialists by driving up the cost of biologic therapies (dupilumab) and endoscopic sinus surgery instruments sourced from Belgium and Italy, exacerbating surgical delays, and increasing otolaryngology procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of respiratory diseases is expected to drive growth in the chronic rhinosinusitis with nasal polyps market. These diseases affect the respiratory system, including the lungs and airways, and are influenced by factors such as air pollution, smoking, climate change, infections, occupational exposures, and allergies. Conditions such as asthma and chronic obstructive pulmonary disease (COPD) are increasingly common, leading to higher rates of associated conditions such as CRSwNP. This trend is fueling demand for diagnostic tools, treatments, and surgical interventions. For example, recent data from the National Center for Health Statistics (NCHS) shows an increase in asthma prevalence among U.S. adults from 8.4% in 2021 to 8.7% in 2022, with asthma episodes rising from 3.3% to 3.7% over the same period. As respiratory tract infections become more prevalent, they are expected to further stimulate growth in the chronic rhinosinusitis with nasal polyps market.
Leading companies in the chronic rhinosinusitis with nasal polyps market are prioritizing alternative therapies, such as anti-IL-5 biologics, to improve patient outcomes and strengthen their competitive edge. Anti-IL-5 biologics provide targeted treatment by reducing eosinophilic inflammation in conditions like severe asthma and eosinophilic disorders, enhancing symptom control and quality of life for patients. For instance, in March 2024, Optinose, a U.S.-based pharmaceutical company focused on developing and commercializing innovative products, received U.S. Food and Drug Administration (FDA) approval for XHANCE, a prescription nasal spray indicated for chronic rhinosinusitis (CRS) in adults, including both chronic rhinosinusitis with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP). It contains fluticasone propionate, a corticosteroid that reduces nasal passage inflammation. A key feature is its unique Exhalation Delivery System (EDS), enabling patients to exhale into the device while administering the spray, which enhances medication delivery deep into the nasal passages, effectively targeting areas where nasal polyps form and sinuses drain.
In May 2022, Medtronic Plc, a US-based medical technology solutions company, completed the acquisition of Intersect ENT Inc. for an undisclosed amount. The acquisition adds Intersect ENT's PROPEL and SINUVA sinus implant product lines and technology to Medtronic's existing ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical technology company specializing in treating chronic rhinosinusitis with nasal polyps.
Major companies operating in the chronic rhinosinusitis with nasal polyps market are Pfizer Inc., Roche Holding AG, Merck & Co Inc, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Boehringer Ingelheim International GmbH, Amgen Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Daiichi Sankyo Company Limited, Olympus Corporation, Eisai Co Ltd, Smith & Nephew PLC, Genentech USA Inc, Mallinckrodt Pharmaceuticals, Lyra Therapeutics Inc, Sunovion Pharmaceuticals, Acclarent Inc., Optinose US Inc, SinuSys Corporation, Biohaven Pharmaceuticals
North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2024. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the chronic rhinosinusitis with nasal polyps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic rhinosinusitis with nasal polyps market consists of revenues earned by entities by providing services such as medical consultations, diagnostic procedures, pharmacological treatments, and surgical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic rhinosinusitis with nasal polyps market also includes sales of nasal corticosteroid sprays, antihistamines, saline nasal sprays, and devices for nasal irrigation, as well as surgical instruments and equipment used in procedures such as polypectomy and functional endoscopic sinus surgery. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Rhinosinusitis With Nasal Polyps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chronic rhinosinusitis with nasal polyps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chronic rhinosinusitis with nasal polyps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic rhinosinusitis with nasal polyps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Medications; Surgical Methods
2) By Route Of Administration: Nasal; Oral; Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Medications: Corticosteroids (Nasal Sprays, Oral Steroids); Biologics (Monoclonal Antibodies Like Dupilumab); Antibiotics; Antihistamines; Leukotriene Modifiers
2) By Surgical Methods: Endoscopic Sinus Surgery (ESS); Polypectomy (Polyps Removal); Balloon Sinuplasty
Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co Inc; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Medtronic plc; Boehringer Ingelheim International GmbH; Amgen Inc; Teva Pharmaceutical Industries Ltd; Regeneron Pharmaceuticals Inc; Daiichi Sankyo Company Limited; Olympus Corporation; Eisai Co Ltd; Smith & Nephew PLC; Genentech USA Inc; Mallinckrodt Pharmaceuticals; Lyra Therapeutics Inc; Sunovion Pharmaceuticals; Acclarent Inc.; Optinose US Inc; SinuSys Corporation; Biohaven Pharmaceuticals
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Chronic Rhinosinusitis With Nasal Polyps Market Characteristics
3. Chronic Rhinosinusitis With Nasal Polyps Market Trends And Strategies
4. Chronic Rhinosinusitis With Nasal Polyps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Chronic Rhinosinusitis With Nasal Polyps Growth Analysis And Strategic Analysis Framework
5.1. Global Chronic Rhinosinusitis With Nasal Polyps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Rhinosinusitis With Nasal Polyps Market Growth Rate Analysis
5.4. Global Chronic Rhinosinusitis With Nasal Polyps Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Rhinosinusitis With Nasal Polyps Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Rhinosinusitis With Nasal Polyps Total Addressable Market (TAM)
6. Chronic Rhinosinusitis With Nasal Polyps Market Segmentation
6.1. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Surgical Methods
6.2. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nasal
Oral
Other Routes Of Administration
6.3. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Chronic Rhinosinusitis With Nasal Polyps Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids (Nasal Sprays, Oral Steroids)
Biologics (Monoclonal Antibodies Like Dupilumab)
Antibiotics
Antihistamines
Leukotriene Modifiers
6.5. Global Chronic Rhinosinusitis With Nasal Polyps Market, Sub-Segmentation Of Surgical Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endoscopic Sinus Surgery (ESS)
Polypectomy (Polyps Removal)
Balloon Sinuplasty
7. Chronic Rhinosinusitis With Nasal Polyps Market Regional And Country Analysis
7.1. Global Chronic Rhinosinusitis With Nasal Polyps Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Rhinosinusitis With Nasal Polyps Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market
8.1. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Chronic Rhinosinusitis With Nasal Polyps Market
9.1. China Chronic Rhinosinusitis With Nasal Polyps Market Overview
9.2. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Chronic Rhinosinusitis With Nasal Polyps Market
10.1. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Chronic Rhinosinusitis With Nasal Polyps Market
11.1. Japan Chronic Rhinosinusitis With Nasal Polyps Market Overview
11.2. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Chronic Rhinosinusitis With Nasal Polyps Market
12.1. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market
13.1. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Chronic Rhinosinusitis With Nasal Polyps Market
14.1. South Korea Chronic Rhinosinusitis With Nasal Polyps Market Overview
14.2. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market
15.1. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market Overview
15.2. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Chronic Rhinosinusitis With Nasal Polyps Market
16.1. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Chronic Rhinosinusitis With Nasal Polyps Market
17.1. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Chronic Rhinosinusitis With Nasal Polyps Market
18.1. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Chronic Rhinosinusitis With Nasal Polyps Market
19.1. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Chronic Rhinosinusitis With Nasal Polyps Market
20.1. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market
21.1. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market Overview
21.2. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Chronic Rhinosinusitis With Nasal Polyps Market
22.1. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Chronic Rhinosinusitis With Nasal Polyps Market
23.1. North America Chronic Rhinosinusitis With Nasal Polyps Market Overview
23.2. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Chronic Rhinosinusitis With Nasal Polyps Market
24.1. USA Chronic Rhinosinusitis With Nasal Polyps Market Overview
24.2. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Chronic Rhinosinusitis With Nasal Polyps Market
25.1. Canada Chronic Rhinosinusitis With Nasal Polyps Market Overview
25.2. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Chronic Rhinosinusitis With Nasal Polyps Market
26.1. South America Chronic Rhinosinusitis With Nasal Polyps Market Overview
26.2. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Chronic Rhinosinusitis With Nasal Polyps Market
27.1. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Chronic Rhinosinusitis With Nasal Polyps Market
28.1. Middle East Chronic Rhinosinusitis With Nasal Polyps Market Overview
28.2. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Chronic Rhinosinusitis With Nasal Polyps Market
29.1. Africa Chronic Rhinosinusitis With Nasal Polyps Market Overview
29.2. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Chronic Rhinosinusitis With Nasal Polyps Market Competitive Landscape And Company Profiles
30.1. Chronic Rhinosinusitis With Nasal Polyps Market Competitive Landscape
30.2. Chronic Rhinosinusitis With Nasal Polyps Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Chronic Rhinosinusitis With Nasal Polyps Market Other Major And Innovative Companies
31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca PLC
31.3. Novartis AG
31.4. GlaxoSmithKline plc
31.5. Takeda Pharmaceutical Company Limited
31.6. Medtronic plc
31.7. Boehringer Ingelheim International GmbH
31.8. Amgen Inc
31.9. Teva Pharmaceutical Industries Ltd
31.10. Regeneron Pharmaceuticals Inc
31.11. Daiichi Sankyo Company Limited
31.12. Olympus Corporation
31.13. Eisai Co Ltd
31.14. Smith & Nephew PLC
31.15. Genentech USA Inc
32. Global Chronic Rhinosinusitis With Nasal Polyps Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Chronic Rhinosinusitis With Nasal Polyps Market
34. Recent Developments In The Chronic Rhinosinusitis With Nasal Polyps Market
35. Chronic Rhinosinusitis With Nasal Polyps Market High Potential Countries, Segments and Strategies
35.1 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Countries Offering Most New Opportunities
35.2 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Segments Offering Most New Opportunities
35.3 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Growth Strategies
